Irene Norstedt works at the European Commission, where she is the acting Director responsible for the Health Directorate within the DG for Research and Innovation, European Commission. She is alsoHead of the Innovative and Personalised Medicine Unit.
She has been at the European Commission since 1996, and was instrumental in the creation of the Innovative Medicines Initiative (IMI) in 2008.
From 16 December 2014 to15 September 2015, Irene served as Acting Executive Director of the Innovative Medicines Initiative.
Prior to joining the European Commission, she worked for the Swedish life science company Biacore AB and at the Swedish embassy in London.
Irene studied biotechnology and polymer science, and holds a Master of Science (MsC) in Chemical Engineering.